Dr. Auriel Willette and his team of researchers have been looking at how a biomarker, insulin-like growth factor binding protein 2 (IGFBP-2), may play a role in a person’s likelihood to develop Alzheimer’s disease. Photo by Ryan Riley/College of Human Sciences.

Iowa State researcher continues search for cause of Alzheimer’s

Dr. Auriel Willette and his team of researchers are continuing their look into how obesity-related problems are linked to metabolism and diabetes.

The outcomes of their latest research, published in the Journal of Alzheimer’s Disease, point to a new biomarker, insulin-like growth factor binding protein 2 (IGFBP-2), and how it may play a role in a person’s likelihood to develop Alzheimer’s disease. IGFBP-2 helps to regulate energy metabolism by affecting blood glucose levels.

See the complete story by the Department of Food Science and Human Nutrition.